SEC-sourced researchBeta
FATE
FATE THERAPEUTICS INC
Company comparison ↗
Data passport
- CIK
- 0001434316
- Exchange
- Nasdaq
- Business activity
- — · SIC 2836
- Financial inputs
- 5/6
- Filing date
- Sep 28, 2026
- SEC registry record
- Operating company
Annual financial history
Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.
| Period end | Revenue | Filing date |
|---|---|---|
| December 2024 | 13,631,000.0000 | Feb 26, 2026 |
| December 2025 | 6,646,000.0000 | Feb 26, 2026 |
Annual periods · USD
| Period end | Revenue | Net income | Operating cash flow | Total assets | Total liabilities | Filing date |
|---|---|---|---|---|---|---|
| December 2025 | 6,646,000.0000 | -136,315,000.0000 | -106,084,000.0000 | 318,937,000.0000 | — | Feb 26, 2026 |
| December 2024 | 13,631,000.0000 | -186,262,000.0000 | -122,874,000.0000 | 440,694,000.0000 | — | Feb 26, 2026 |
Financial inputs behind the calculation
| Financial inputs | USD | Period end | Filing date | Form |
|---|---|---|---|---|
| RevenueRevenueFromContractWithCustomerExcludingAssessedTax | $6.65M | December 2025 | Feb 26, 2026 | 10-K |
| Previous period revenueRevenueFromContractWithCustomerExcludingAssessedTax | $13.63M | December 2024 | Feb 26, 2026 | 10-K |
| Net incomeNetIncomeLoss | -$136.32M | December 2025 | Feb 26, 2026 | 10-K |
| Operating cash flowNetCashProvidedByUsedInOperatingActivities | -$106.08M | December 2025 | Feb 26, 2026 | 10-K |
| Total assetsAssets | $318.94M | December 2025 | Feb 26, 2026 | 10-K |
| Total liabilities | — | — | — | — |